Effects of methylphenidate on mismatch negativity and P3a amplitude of initially psychostimulant-naïve, adult ADHD patients
Deficient information processing in ADHD theoretically results in sensory overload and may underlie the symptoms of the disorder. Mismatch negativity (MMN) and P3a amplitude reflect an individual's detection and subsequent change in attention to stimulus change in their environment. Our primary...
Gespeichert in:
Veröffentlicht in: | Psychological medicine 2023-02, Vol.53 (3), p.957-965 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 965 |
---|---|
container_issue | 3 |
container_start_page | 957 |
container_title | Psychological medicine |
container_volume | 53 |
creator | le Sommer, Julijana Low, Ann-Marie Møllegaard Jepsen, Jens Richardt Fagerlund, Birgitte Vangkilde, Signe Habekost, Thomas Glenthøj, Birte Oranje, Bob |
description | Deficient information processing in ADHD theoretically results in sensory overload and may underlie the symptoms of the disorder. Mismatch negativity (MMN) and P3a amplitude reflect an individual's detection and subsequent change in attention to stimulus change in their environment. Our primary aim was to explore MMN and P3a amplitude in adult ADHD patients and to examine the effects of methylphenidate (MPH) on these measures.
Forty initially psychostimulant-naïve, adult ADHD patients without comorbid ASD and 42 matched healthy controls (HC) were assessed with an MMN paradigm at baseline. Both groups were retested after 6 weeks, in which patients were treated with MPH.
Neither significant group differences in MMN nor P3a amplitude were found at baseline. Although 6-week MPH treatment significantly reduced symptomatology and improved daily functioning of the patients, it did not significantly affect MMN amplitude; however, it did significantly reduce P3a amplitude compared to the HC. Furthermore, more severe ADHD symptoms were significantly associated with larger MMN amplitudes in the patients, both at baseline and follow-up.
We found no evidence for early information processing deficits in patients with ADHD, as measured with MMN and P3a amplitude. Six-week treatment with MPH decreased P3a but not MMN amplitude, although more severe ADHD-symptoms were associated with larger MMN amplitudes in the patients. Given that P3a amplitude represents an important attentional process and that glutamate has been linked to both ADHD and MMN amplitude, future research should investigate augmenting MPH treatment of less responsive adults with ADHD with glutamatergic antagonists. |
doi_str_mv | 10.1017/S0033291721002373 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2548602901</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cupid>10_1017_S0033291721002373</cupid><sourcerecordid>2548602901</sourcerecordid><originalsourceid>FETCH-LOGICAL-c373t-8b4c46656e51bae8df5f4cedf893b80791c7bb3fe7172ae08e34b6007191de913</originalsourceid><addsrcrecordid>eNp1kctO3TAURS3UqlygH8AEWeqEAWn9SGJniC5PCamVgHHk2Mdco8QJsYMUiX_iI_pjdcRtkVp1dAZn7X0eG6FDSr5SQsW3W0I4ZxUVjBLCuOA7aEXzsspkJeQHtFra2dLfRXshPBJCOc3ZJ7TLc0al5MUKvZxbCzoG3FvcQdzM7bAB74yKgHuPOxc6FfUGe3hQ0T27OGPlDf7BFVbd0Lo4GVi0zrvoVNvOeAiz3vQhum5qlY-ZVz9fn-EEKzO1EZ-eXZ3hIVmBj-EAfbSqDfB5W_fR_cX53foqu_l-eb0-vcl0uilmssl1XpZFCQVtFEhjC5trMFZWvJFEVFSLpuEWRPqEAiKB501JiKAVNVBRvo-O33yHsX-aIMQ63aWhTftBP4WaFbksCavIgn75C33sp9Gn7WomJClKyUqRKPpG6bEPYQRbD6Pr1DjXlNRLNPU_0STN0dZ5ajowfxS_s0gA35qqrhmdeYD32f-3_QUD1Jnk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2780568267</pqid></control><display><type>article</type><title>Effects of methylphenidate on mismatch negativity and P3a amplitude of initially psychostimulant-naïve, adult ADHD patients</title><source>MEDLINE</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Cambridge University Press Journals Complete</source><creator>le Sommer, Julijana ; Low, Ann-Marie ; Møllegaard Jepsen, Jens Richardt ; Fagerlund, Birgitte ; Vangkilde, Signe ; Habekost, Thomas ; Glenthøj, Birte ; Oranje, Bob</creator><creatorcontrib>le Sommer, Julijana ; Low, Ann-Marie ; Møllegaard Jepsen, Jens Richardt ; Fagerlund, Birgitte ; Vangkilde, Signe ; Habekost, Thomas ; Glenthøj, Birte ; Oranje, Bob</creatorcontrib><description>Deficient information processing in ADHD theoretically results in sensory overload and may underlie the symptoms of the disorder. Mismatch negativity (MMN) and P3a amplitude reflect an individual's detection and subsequent change in attention to stimulus change in their environment. Our primary aim was to explore MMN and P3a amplitude in adult ADHD patients and to examine the effects of methylphenidate (MPH) on these measures.
Forty initially psychostimulant-naïve, adult ADHD patients without comorbid ASD and 42 matched healthy controls (HC) were assessed with an MMN paradigm at baseline. Both groups were retested after 6 weeks, in which patients were treated with MPH.
Neither significant group differences in MMN nor P3a amplitude were found at baseline. Although 6-week MPH treatment significantly reduced symptomatology and improved daily functioning of the patients, it did not significantly affect MMN amplitude; however, it did significantly reduce P3a amplitude compared to the HC. Furthermore, more severe ADHD symptoms were significantly associated with larger MMN amplitudes in the patients, both at baseline and follow-up.
We found no evidence for early information processing deficits in patients with ADHD, as measured with MMN and P3a amplitude. Six-week treatment with MPH decreased P3a but not MMN amplitude, although more severe ADHD-symptoms were associated with larger MMN amplitudes in the patients. Given that P3a amplitude represents an important attentional process and that glutamate has been linked to both ADHD and MMN amplitude, future research should investigate augmenting MPH treatment of less responsive adults with ADHD with glutamatergic antagonists.</description><identifier>ISSN: 0033-2917</identifier><identifier>EISSN: 1469-8978</identifier><identifier>DOI: 10.1017/S0033291721002373</identifier><identifier>PMID: 34218835</identifier><language>eng</language><publisher>Cambridge, UK: Cambridge University Press</publisher><subject>Adult ; Adults ; Attention Deficit Disorder with Hyperactivity - drug therapy ; Attention deficit hyperactivity disorder ; Attentional processes ; Cognition ; Comorbidity ; Dopamine ; Drug abuse ; Electroencephalography - methods ; Glutamatergic transmission ; Humans ; Hyperactivity ; Information processing ; Mental disorders ; Methylphenidate ; Methylphenidate - pharmacology ; Methylphenidate - therapeutic use ; Mismatch negativity ; Original Article ; Psychosis ; Schizophrenia ; Stimulus ; Visual evoked potentials</subject><ispartof>Psychological medicine, 2023-02, Vol.53 (3), p.957-965</ispartof><rights>Copyright © The Author(s), 2021. Published by Cambridge University Press</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c373t-8b4c46656e51bae8df5f4cedf893b80791c7bb3fe7172ae08e34b6007191de913</citedby><cites>FETCH-LOGICAL-c373t-8b4c46656e51bae8df5f4cedf893b80791c7bb3fe7172ae08e34b6007191de913</cites><orcidid>0000-0002-3416-5562</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.cambridge.org/core/product/identifier/S0033291721002373/type/journal_article$$EHTML$$P50$$Gcambridge$$H</linktohtml><link.rule.ids>164,314,780,784,12846,27924,27925,30999,55628</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34218835$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>le Sommer, Julijana</creatorcontrib><creatorcontrib>Low, Ann-Marie</creatorcontrib><creatorcontrib>Møllegaard Jepsen, Jens Richardt</creatorcontrib><creatorcontrib>Fagerlund, Birgitte</creatorcontrib><creatorcontrib>Vangkilde, Signe</creatorcontrib><creatorcontrib>Habekost, Thomas</creatorcontrib><creatorcontrib>Glenthøj, Birte</creatorcontrib><creatorcontrib>Oranje, Bob</creatorcontrib><title>Effects of methylphenidate on mismatch negativity and P3a amplitude of initially psychostimulant-naïve, adult ADHD patients</title><title>Psychological medicine</title><addtitle>Psychol. Med</addtitle><description>Deficient information processing in ADHD theoretically results in sensory overload and may underlie the symptoms of the disorder. Mismatch negativity (MMN) and P3a amplitude reflect an individual's detection and subsequent change in attention to stimulus change in their environment. Our primary aim was to explore MMN and P3a amplitude in adult ADHD patients and to examine the effects of methylphenidate (MPH) on these measures.
Forty initially psychostimulant-naïve, adult ADHD patients without comorbid ASD and 42 matched healthy controls (HC) were assessed with an MMN paradigm at baseline. Both groups were retested after 6 weeks, in which patients were treated with MPH.
Neither significant group differences in MMN nor P3a amplitude were found at baseline. Although 6-week MPH treatment significantly reduced symptomatology and improved daily functioning of the patients, it did not significantly affect MMN amplitude; however, it did significantly reduce P3a amplitude compared to the HC. Furthermore, more severe ADHD symptoms were significantly associated with larger MMN amplitudes in the patients, both at baseline and follow-up.
We found no evidence for early information processing deficits in patients with ADHD, as measured with MMN and P3a amplitude. Six-week treatment with MPH decreased P3a but not MMN amplitude, although more severe ADHD-symptoms were associated with larger MMN amplitudes in the patients. Given that P3a amplitude represents an important attentional process and that glutamate has been linked to both ADHD and MMN amplitude, future research should investigate augmenting MPH treatment of less responsive adults with ADHD with glutamatergic antagonists.</description><subject>Adult</subject><subject>Adults</subject><subject>Attention Deficit Disorder with Hyperactivity - drug therapy</subject><subject>Attention deficit hyperactivity disorder</subject><subject>Attentional processes</subject><subject>Cognition</subject><subject>Comorbidity</subject><subject>Dopamine</subject><subject>Drug abuse</subject><subject>Electroencephalography - methods</subject><subject>Glutamatergic transmission</subject><subject>Humans</subject><subject>Hyperactivity</subject><subject>Information processing</subject><subject>Mental disorders</subject><subject>Methylphenidate</subject><subject>Methylphenidate - pharmacology</subject><subject>Methylphenidate - therapeutic use</subject><subject>Mismatch negativity</subject><subject>Original Article</subject><subject>Psychosis</subject><subject>Schizophrenia</subject><subject>Stimulus</subject><subject>Visual evoked potentials</subject><issn>0033-2917</issn><issn>1469-8978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1kctO3TAURS3UqlygH8AEWeqEAWn9SGJniC5PCamVgHHk2Mdco8QJsYMUiX_iI_pjdcRtkVp1dAZn7X0eG6FDSr5SQsW3W0I4ZxUVjBLCuOA7aEXzsspkJeQHtFra2dLfRXshPBJCOc3ZJ7TLc0al5MUKvZxbCzoG3FvcQdzM7bAB74yKgHuPOxc6FfUGe3hQ0T27OGPlDf7BFVbd0Lo4GVi0zrvoVNvOeAiz3vQhum5qlY-ZVz9fn-EEKzO1EZ-eXZ3hIVmBj-EAfbSqDfB5W_fR_cX53foqu_l-eb0-vcl0uilmssl1XpZFCQVtFEhjC5trMFZWvJFEVFSLpuEWRPqEAiKB501JiKAVNVBRvo-O33yHsX-aIMQ63aWhTftBP4WaFbksCavIgn75C33sp9Gn7WomJClKyUqRKPpG6bEPYQRbD6Pr1DjXlNRLNPU_0STN0dZ5ajowfxS_s0gA35qqrhmdeYD32f-3_QUD1Jnk</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>le Sommer, Julijana</creator><creator>Low, Ann-Marie</creator><creator>Møllegaard Jepsen, Jens Richardt</creator><creator>Fagerlund, Birgitte</creator><creator>Vangkilde, Signe</creator><creator>Habekost, Thomas</creator><creator>Glenthøj, Birte</creator><creator>Oranje, Bob</creator><general>Cambridge University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7QJ</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3416-5562</orcidid></search><sort><creationdate>20230201</creationdate><title>Effects of methylphenidate on mismatch negativity and P3a amplitude of initially psychostimulant-naïve, adult ADHD patients</title><author>le Sommer, Julijana ; Low, Ann-Marie ; Møllegaard Jepsen, Jens Richardt ; Fagerlund, Birgitte ; Vangkilde, Signe ; Habekost, Thomas ; Glenthøj, Birte ; Oranje, Bob</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c373t-8b4c46656e51bae8df5f4cedf893b80791c7bb3fe7172ae08e34b6007191de913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adult</topic><topic>Adults</topic><topic>Attention Deficit Disorder with Hyperactivity - drug therapy</topic><topic>Attention deficit hyperactivity disorder</topic><topic>Attentional processes</topic><topic>Cognition</topic><topic>Comorbidity</topic><topic>Dopamine</topic><topic>Drug abuse</topic><topic>Electroencephalography - methods</topic><topic>Glutamatergic transmission</topic><topic>Humans</topic><topic>Hyperactivity</topic><topic>Information processing</topic><topic>Mental disorders</topic><topic>Methylphenidate</topic><topic>Methylphenidate - pharmacology</topic><topic>Methylphenidate - therapeutic use</topic><topic>Mismatch negativity</topic><topic>Original Article</topic><topic>Psychosis</topic><topic>Schizophrenia</topic><topic>Stimulus</topic><topic>Visual evoked potentials</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>le Sommer, Julijana</creatorcontrib><creatorcontrib>Low, Ann-Marie</creatorcontrib><creatorcontrib>Møllegaard Jepsen, Jens Richardt</creatorcontrib><creatorcontrib>Fagerlund, Birgitte</creatorcontrib><creatorcontrib>Vangkilde, Signe</creatorcontrib><creatorcontrib>Habekost, Thomas</creatorcontrib><creatorcontrib>Glenthøj, Birte</creatorcontrib><creatorcontrib>Oranje, Bob</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>Proquest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Psychological medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>le Sommer, Julijana</au><au>Low, Ann-Marie</au><au>Møllegaard Jepsen, Jens Richardt</au><au>Fagerlund, Birgitte</au><au>Vangkilde, Signe</au><au>Habekost, Thomas</au><au>Glenthøj, Birte</au><au>Oranje, Bob</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of methylphenidate on mismatch negativity and P3a amplitude of initially psychostimulant-naïve, adult ADHD patients</atitle><jtitle>Psychological medicine</jtitle><addtitle>Psychol. Med</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>53</volume><issue>3</issue><spage>957</spage><epage>965</epage><pages>957-965</pages><issn>0033-2917</issn><eissn>1469-8978</eissn><abstract>Deficient information processing in ADHD theoretically results in sensory overload and may underlie the symptoms of the disorder. Mismatch negativity (MMN) and P3a amplitude reflect an individual's detection and subsequent change in attention to stimulus change in their environment. Our primary aim was to explore MMN and P3a amplitude in adult ADHD patients and to examine the effects of methylphenidate (MPH) on these measures.
Forty initially psychostimulant-naïve, adult ADHD patients without comorbid ASD and 42 matched healthy controls (HC) were assessed with an MMN paradigm at baseline. Both groups were retested after 6 weeks, in which patients were treated with MPH.
Neither significant group differences in MMN nor P3a amplitude were found at baseline. Although 6-week MPH treatment significantly reduced symptomatology and improved daily functioning of the patients, it did not significantly affect MMN amplitude; however, it did significantly reduce P3a amplitude compared to the HC. Furthermore, more severe ADHD symptoms were significantly associated with larger MMN amplitudes in the patients, both at baseline and follow-up.
We found no evidence for early information processing deficits in patients with ADHD, as measured with MMN and P3a amplitude. Six-week treatment with MPH decreased P3a but not MMN amplitude, although more severe ADHD-symptoms were associated with larger MMN amplitudes in the patients. Given that P3a amplitude represents an important attentional process and that glutamate has been linked to both ADHD and MMN amplitude, future research should investigate augmenting MPH treatment of less responsive adults with ADHD with glutamatergic antagonists.</abstract><cop>Cambridge, UK</cop><pub>Cambridge University Press</pub><pmid>34218835</pmid><doi>10.1017/S0033291721002373</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-3416-5562</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0033-2917 |
ispartof | Psychological medicine, 2023-02, Vol.53 (3), p.957-965 |
issn | 0033-2917 1469-8978 |
language | eng |
recordid | cdi_proquest_miscellaneous_2548602901 |
source | MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); Cambridge University Press Journals Complete |
subjects | Adult Adults Attention Deficit Disorder with Hyperactivity - drug therapy Attention deficit hyperactivity disorder Attentional processes Cognition Comorbidity Dopamine Drug abuse Electroencephalography - methods Glutamatergic transmission Humans Hyperactivity Information processing Mental disorders Methylphenidate Methylphenidate - pharmacology Methylphenidate - therapeutic use Mismatch negativity Original Article Psychosis Schizophrenia Stimulus Visual evoked potentials |
title | Effects of methylphenidate on mismatch negativity and P3a amplitude of initially psychostimulant-naïve, adult ADHD patients |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T05%3A52%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20methylphenidate%20on%20mismatch%20negativity%20and%20P3a%20amplitude%20of%20initially%20psychostimulant-na%C3%AFve,%20adult%20ADHD%20patients&rft.jtitle=Psychological%20medicine&rft.au=le%20Sommer,%20Julijana&rft.date=2023-02-01&rft.volume=53&rft.issue=3&rft.spage=957&rft.epage=965&rft.pages=957-965&rft.issn=0033-2917&rft.eissn=1469-8978&rft_id=info:doi/10.1017/S0033291721002373&rft_dat=%3Cproquest_cross%3E2548602901%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2780568267&rft_id=info:pmid/34218835&rft_cupid=10_1017_S0033291721002373&rfr_iscdi=true |